Lallemand Executive and Leadership Team

Audrey St. Onge, the Baking Business President & Chief Executive Officer (North America) at Lallemand, directs all regional operations regarding yeast and baking ingredient production. Overseeing the North American market, the Baking Business President & Chief Executive Officer (North America) ensures that manufacturing processes meet the rigorous quality standards required by the food industry. This leadership role involves coordinating with research teams to develop high-performance fermentation products that support commercial bakeries across the continent. By optimizing supply chain logistics and production capacity, Audrey St. Onge directly impacts the market share of the baking division. St. Onge maintains alignment with corporate sustainability goals while driving revenue growth through strategic partnerships with major food manufacturers. The Baking Business President & Chief Executive Officer (North America) also manages the integration of new microbial technologies into existing product lines to enhance shelf life and dough consistency for industrial clients.

Antoine Chagnon, the President & Chief Executive Officer at Lallemand, directs the global strategic vision for the development and marketing of microorganisms. Overseeing the entire corporate portfolio, the President & Chief Executive Officer ensures that the company maintains a competitive edge in the health, nutrition, and industrial fermentation sectors. This leadership role involves guiding the executive board through complex international expansion efforts and capital investment decisions. By fostering a culture of scientific excellence, Antoine Chagnon drives the long-term growth of the organization across diverse industries including oenology, brewing, and biofuels. Chagnon manages the alignment of global business units to ensure consistent delivery of high-quality microbiological solutions. The President & Chief Executive Officer also monitors market trends to identify new opportunities for product diversification, ensuring that the company remains at the forefront of biotechnology while delivering value to stakeholders and maintaining operational excellence on a global scale.

Francine Mondou, the Prïsidente and Chief Executive Officer at Lallemand, directs specific administrative and strategic initiatives focused on organizational governance and corporate development. Overseeing the integration of business processes, the Prïsidente and Chief Executive Officer ensures that the company maintains high standards of operational integrity and financial performance. This leadership role involves collaborating with the board to refine the long-term vision for the organization, particularly regarding the expansion of microbiological applications in emerging markets. By streamlining internal communication and decision-making frameworks, Francine Mondou directly impacts the agility of the company in responding to market shifts. Mondou manages the alignment of departmental goals with the overarching mission of providing innovative microbial solutions. The Prïsidente and Chief Executive Officer also evaluates potential acquisitions and partnerships that enhance the company's technological capabilities, ensuring that the organization remains a leader in the global biotechnology sector through disciplined management and strategic foresight.

William Nankervis, the Executive Vice President & Chief Operating Officer at Lallemand, directs the daily operational activities and manufacturing infrastructure across all global facilities. Overseeing the production of yeasts, bacteria, and fungi, the Executive Vice President & Chief Operating Officer ensures that internal processes remain efficient and scalable. This leadership role involves managing cross-functional teams to optimize the supply chain and maintain rigorous quality control standards for food ingredients and health products. By implementing advanced manufacturing technologies, William Nankervis directly impacts the operational output and cost-effectiveness of the company. Nankervis coordinates with the executive team to align production capabilities with global demand, ensuring that the organization meets the needs of diverse industries from biofuels to animal nutrition. The Executive Vice President & Chief Operating Officer also monitors facility performance to ensure compliance with international safety regulations while driving continuous improvement initiatives throughout the entire global manufacturing network.

Kevin Bergeron, the Co President Santé Sécurité at Lallemand, directs the health and safety protocols across all manufacturing and research environments. Overseeing the implementation of rigorous safety standards, the Co President Santé Sécurité ensures that the company protects its workforce while maintaining compliance with international health regulations. This leadership role involves developing comprehensive risk management strategies that address the unique challenges of handling microorganisms and chemical derivatives. By fostering a culture of safety, Kevin Bergeron directly impacts the operational continuity and reputation of the organization. Bergeron coordinates with facility managers to audit safety performance and integrate best practices into daily workflows. The Co President Santé Sécurité also monitors global health trends to ensure that the company remains proactive in addressing potential workplace hazards. Through the application of advanced safety metrics, the Co President Santé Sécurité supports the company's commitment to sustainable and responsible production practices across all global operations.

Sheryl Lallemand, the President at Lallemand, directs high-level corporate initiatives and represents the company's interests in key strategic markets. Overseeing the alignment of brand values with business objectives, the President ensures that the organization maintains its reputation for excellence in the development of microorganisms. This leadership role involves engaging with key stakeholders and industry partners to promote the company's diverse portfolio of solutions, ranging from human health to industrial applications. By providing strategic guidance on market positioning, Sheryl Lallemand directly impacts the long-term growth trajectory of the company. Lallemand manages the communication of the corporate mission to ensure that all business units remain focused on innovation and quality. The President also monitors the competitive landscape to identify opportunities for brand expansion and market penetration. Through consistent leadership, the President supports the company's efforts to deliver high-value microbiological products that address the evolving needs of global industries and consumers.

Jerome Panes, the Lallemand Health Solutions BU President & General Manager at Lallemand, directs the development and commercialization of probiotic and health-focused microbial products. Overseeing the health solutions business unit, the Lallemand Health Solutions BU President & General Manager ensures that the company delivers evidence-based solutions to the human health and nutrition sectors. This leadership role involves managing the research-to-market pipeline for specialized bacteria and yeast strains. By driving innovation in clinical research and product formulation, Jerome Panes directly impacts the company's success in the competitive health supplement market. Panes coordinates with global sales teams to expand the reach of health solutions into new geographic regions. The Lallemand Health Solutions BU President & General Manager also monitors regulatory developments to ensure that all products meet the highest standards of efficacy and safety. Through strategic management of the business unit, Panes supports the company's mission to improve human health through advanced microbiological science.